Alembic Pharmaceuticals Ltd.

View in App
754.00 +8.10 ▲1.1%

01 December 2023, 04:01:00 PM
Volume: 18,139

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.alembicpharmaceuticals.com
Market Cap 14,763.86 Cr.
Enterprise Value(EV) 15,400.44 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 27.05 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 27.77 Trailing Twelve Months Ending 2023-09
Industry PE 38.75 Trailing Twelve Months Ending 2023-09
Book Value / Share 227.41 Trailing Twelve Months Ending 2023-09
Price to Book Value 3.30 Calculated using Price: 751.10
Dividend Yield 1.07 Period Ending 2023-03
No. of Shares Subscribed 19.66 Cr. 196,563,124 Shares
FaceValue 2
About Alembic Pharmaceuticals Ltd.
The company is principally engaged in the manufacturing and selling of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company presents an extensive range of branded and generic formulations, in compliance with international and national regulations, that cater to diverse therapeutic segments.

Alembic Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Alembic Pharmaceuticals Ltd. Performance

View details >>
1 Day
+1.09%
1 Week
+4.15%
1 Month
+2.84%
3 Month
-2.10%
6 Month
+35.73%
1 Year
+26.72%
2 Year
-6.49%
5 Year
+22.26%
10 Year
+268.07%

Alembic Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 36.24 58.02 23.25 20.42 24.00 26.97 26.91 10.11 7.12
Return on Capital Employed (%) 37.54 65.86 28.87 22.15 22.66 23.30 26.28 11.25 7.44
Return on Assets (%) 18.76 33.75 14.97 12.25 13.15 14.64 17.22 7.34 5.15

Alembic Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 885 1,597 1,902 2,220 2,719 3,219 5,067 5,238 4,370 4,470
Non Curr. Liab. 72 84 94 576 570 1,047 361 162 52 52
Curr. Liab. 684 944 814 1,267 1,664 1,752 1,533 1,831 1,641 1,810
Minority Int. 0 0 -1 -29
Equity & Liab. 1,641 2,626 2,811 4,064 4,952 5,989 6,961 7,230 6,064 6,332
Non Curr. Assets 750 917 1,317 2,116 2,820 3,526 4,057 4,255 3,150 3,197
Curr. Assets 891 1,708 1,494 1,948 2,132 2,463 2,904 2,975 2,914 3,134
Misc. Exp. not W/O
Total Assets 1,641 2,626 2,811 4,064 4,952 5,989 6,961 7,230 6,064 6,332

Alembic Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 2,056 3,166 3,135 3,131 3,935 4,606 5,393 5,306 5,653 5,997
Other Income 12 9 3 35 27 14 87 50 3 23
Total Income 2,068 3,175 3,137 3,166 3,962 4,620 5,481 5,356 5,656 6,020
Total Expenditure -1,661 -2,161 -2,520 -2,516 -3,079 -3,392 -3,913 -4,432 -4,945 -5,129
PBIDT 407 1,014 617 650 883 1,228 1,568 925 711 891
Interest -4 -5 -5 -3 -18 -27 -16 -18 -50 -59
Depreciation -44 -72 -83 -105 -115 -157 -183 -287 -275 -274
Taxation -76 -216 -122 -120 -157 -199 -253 -104 -13 -3
Exceptional Items -44
PAT 283 720 407 421 593 801 1,115 521 342 554
Minority Interest 0 0 1 28
Share Associate 0 -4 -8 -9 0 32 -23
Other Related Items
Consolidated Net Profit 283 720 403 413 584 829 1,147 521 342 532
Adjusted EPS 15 38 21 22 31 44 58 27 17 27

Alembic Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 240 172 948 329 312 812 449 1,463 552 724
Cash Fr. Inv. -81 -256 -307 -486 -884 -756 -732 -839 -372 -448
Cash Fr. Finan. -151 87 -224 -129 503 59 155 -597 -217 -262
Net Change 8 3 417 -286 -69 115 -128 27 -37 14
Cash & Cash Eqvt 24 27 439 153 84 199 72 98 61 75

Alembic Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 69.48 69.48 69.61 69.61 69.61 69.61 69.61 69.61 69.61
Public 30.52 30.52 30.39 30.39 30.39 30.39 30.39 30.39 30.39
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Alembic Pharmaceuticals Ltd. Announcements

View details >>
Wed, 29 Nov 2023
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DSP Trustee Pvt Ltd & Others
Mon, 27 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached the intimation of loss of Share Certificates.
Mon, 27 Nov 2023
Announcement under Regulation 30 (LODR)-Change in Management
Appointment of SMP

Alembic Pharmaceuticals Ltd. Technical Scans

View details >>
Fri, 01 Dec 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months
Closing Near 50 SMA Closing Near 50 SMA

Alembic Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Alembic Pharmaceuticals Ltd. FAQ's

What is Alembic Pharma share price?
Can I buy Alembic Pharma shares now?
What is the Dividend Yield of Alembic Pharma?
What is the Market Cap of Alembic Pharma?
What are the key metrics to analyse Alembic Pharma?
What is the 52 Week High and Low of Alembic Pharma?
What is the trend of Alembic Pharma share price?